Evidence map›Paper›PMID 22052666›Full record

ReviewReviews in medical virology2012

Chromosomally integrated human herpesvirus 6: questions and answers.

Philip E Pellett, Dharam V Ablashi, Peter F Ambros, Henri Agut, Mary T Caserta, Vincent Descamps, Louis Flamand, Agnès Gautheret-Dejean, Caroline B Hall, Rammurti T Kamble and 16 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Reviews in medical virology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 154 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
154citing papers in PubMed, 2 pooled it
16.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

154 citing papers in PubMed, 2 syntheses or guidelines pooled it, 373 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Observational
  9. Association betweenFrontiers in microbiology · 2026
    Article
  10. Article
  11. Article
  12. Endogenous human herpesviruses 6A/B.Journal of virology · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

94 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 20 institutions in 9 countries.

Philip E PellettDepartment of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, MI 48201, USA. ppellett@med.wayne.edu
Dharam V Ablashi
Peter F Ambros
Henri Agut
Mary T Caserta
Vincent Descamps
Louis Flamand
Agnès Gautheret-Dejean
Caroline B Hall
Rammurti T Kamble
Uwe Kuehl
Dirk Lassner
Irmeli Lautenschlager
Kristin S Loomis
Mario Luppi
Paolo Lusso
Peter G Medveczky
Jose G Montoya
Yasuko Mori
Masao Ogata
Joshua C Pritchett
Sylvie Rogez
Edward Seto
Katherine N Ward
Tetsushi Yoshikawa
Raymund R Razonable
HHV-6 Foundation · USUniversity of Rochester · USBaylor College of Medicine · USCharité - Universitätsmedizin Berlin · DEFujita Health University · JPHôpital Bichat-Claude-Bernard · FRHôpital Dupuytren · FRKobe University · JPMayo Clinic in Florida · USMolecular Oncology (United States) · USNational Institute of Allergy and Infectious Diseases · USOita University · JPStanford University · USSt Anna Children's Hospital · ATUniversité Laval · CAUniversity College London · GBUniversity of Helsinki · FIUniversity of Modena and Reggio Emilia · ITUniversity of South Florida · USWayne State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromosomally integrated human herpesvirus 6 (ciHHV-6) is a condition in which the complete HHV-6 genome is integrated into the host germ line genome and is vertically transmitted in a Mendelian manner. The condition is found in less than 1% of controls in the USA and UK, but has been found at a somewhat higher prevalence in transplant recipients and other patient populations in several small studies. HHV-6 levels in whole blood that exceed 5.5 log10 copies/ml are strongly suggestive of ciHHV-6. Monitoring DNA load in plasma and serum is unreliable, both for identifying and for monitoring subjects with ciHHV-6 due to cell lysis and release of cellular DNA. High HHV-6 DNA loads associated with ciHHV-6 can lead to erroneous diagnosis of active infection. Transplant recipients with ciHHV-6 may be at increased risk for bacterial infection and graft rejection. ciHHV-6 can be induced to a state of active viral replication in vitro. It is not known whether ciHHV-6 individuals are put at clinical risk by the use of drugs that have been associated with HHV-6 reactivation in vivo or in vitro. Nonetheless, we urge careful observation when use of such drugs is indicated in individuals known to have ciHHV-6. Little is known about whether individuals with ciHHV-6 develop immune tolerance for viral proteins. Further research is needed to determine the role of ciHHV-6 in disease.

Indexed as

Virus IntegrationChromosomes, HumanHerpesvirus 6, HumanHumansRoseolovirus Infections

Identifiers

PMID22052666
PMCPMC3498727
OpenAlexW1831137467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.